Received: 9 September 2020
Accepted: 30 July 2021
First Online: 30 September 2021
: M.L.S. is an equity holder, scientific cofounder and advisory board member of Immunitas Therapeutics. A.R. is a founder and equity holder of Celsius Therapeutics, is an equity holder in Immunitas Therapeutics and, until 31 July 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and ThermoFisher Scientific. Since 1 August 2020, A.R. has been an employee of Genentech. Since 19 October 2020, O.R.-R. has been an employee of Genentech. D.A.L. is an equity holder, scientific cofounder and advisory board member of C2i Genomics and a scientific advisory board member for Mission Bio. The authors declare that these activities are not related to the research reported in this publication and have not influenced the conclusions in this manuscript. The remaining authors declare no competing interests.